Detalles de la búsqueda
1.
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
Oncologist;
2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581687
2.
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer.
Gastric Cancer;
27(1): 155-163, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37989806
3.
Risk factors for early recurrence after radical gastrectomy followed by adjuvant chemotherapy for stage II or III gastric cancer: a multicenter, retrospective study.
Jpn J Clin Oncol;
54(4): 403-415, 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38251775
4.
Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective study.
BMC Cancer;
23(1): 283, 2023 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36978040
5.
Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer.
Cancer Sci;
113(8): 2814-2827, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35701865
6.
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).
Gastric Cancer;
25(1): 235-244, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34427838
7.
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
Gastric Cancer;
25(1): 207-217, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480657
8.
Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices.
Biol Pharm Bull;
45(9): 1246-1253, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047192
9.
Effect of Itraconazole and Its Metabolite Hydroxyitraconazole on the Blood Concentrations of Cyclosporine and Tacrolimus in Lung Transplant Recipients.
Biol Pharm Bull;
45(4): 397-402, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35370263
10.
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.
Int J Clin Oncol;
27(9): 1450-1458, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35861943
11.
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
Gastric Cancer;
24(4): 946-958, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743112
12.
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3).
Esophagus;
18(1): 90-99, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33170461
13.
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Lancet Oncol;
21(8): 1045-1056, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32682457
14.
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
Gastric Cancer;
23(1): 143-153, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31087200
15.
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Gastric Cancer;
23(3): 510-519, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31863227
16.
Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.
Cancer Sci;
110(9): 2875-2883, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31254422
17.
Concentration and Glycoform of Rituximab in Plasma of Patients with B Cell Non-Hodgkin's Lymphoma.
Pharm Res;
36(6): 82, 2019 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30989405
18.
Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin.
Gastric Cancer;
22(1): 138-146, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29948386
19.
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2).
Gastric Cancer;
22(2): 344-354, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30506519
20.
A model-based comparative meta-analysis of the efficacy of dolutegravir-based and efavirenz-based regimens in HIV-infected patients.
J Infect Chemother;
25(9): 687-694, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30982724